Prevalence and Outcomes of Gastrointestinal Manifestations in an Australian Scleroderma Cohort

A Quinlivan; D Hansen; W Stevens; L Ross; N Ferdowsi; SM Proudman; JG Walker; J Sahhar; GS Ngian; D Apostolopoulos; LV Host; G Major; C Basnayake; K Morrisroe; M Nikpour

Journal article

Prevalence and Outcomes of Gastrointestinal Manifestations in an Australian Scleroderma Cohort

A Quinlivan, D Hansen, W Stevens, L Ross, N Ferdowsi, SM Proudman, JG Walker, J Sahhar, GS Ngian, D Apostolopoulos, LV Host, G Major, C Basnayake, K Morrisroe, M Nikpour

Arthritis Care and Research | WILEY | Published : 2024

DOI: 10.1002/acr.25426

Download PDF

Abstract

Objective: The gastrointestinal tract (GIT) is the most commonly affected internal organ in systemic sclerosis (SSc). We sought to determine the prevalence and impact of GIT symptoms on survival and patient-reported outcomes. Methods: A total of 907 consecutive patients from the Australian Scleroderma Cohort Study who had prospectively completed the University of California, Los Angeles, Scleroderma Clinical Trials Consortium Gastrointestinal Tract 2.0 Questionnaire (UCLA GIT) between 2015 and 2021 were included. The associations between UCLA GIT scores and physical function (Scleroderma Health Assessment Questionnaire), quality of life (QoL; Short Form 36), mood (Patient-Reported Outcomes M..

View full abstract

University of Melbourne Researchers

Wendy Stevens Author

Laura Ross Author

Chamara Basnayake Author

Katie Morrisroe Author

Related Projects (1)

IMPROVING OUTCOMES IN SYSTEMIC AUTOIMMUNE DISEASE

My research is focused on improving outcomes of autoimmune diseases scleroderma and lupus, that can affect multiple organs in the body, caus..

Grants

Awarded by Arthritis Australia

Funding Acknowledgements

Open access publishing facilitated by The University of Sydney, as part of the Wiley - The University of Sydney agreement via the Council of Australian University Librarians.